You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

 

CME

HER2 Testing in 2023: Case Studies for Pathologists

  • Authors: Giuseppe Viale, MD, FRCPath; Peter A. Fasching, MD
  • CME Released: 3/14/2023
  • Valid for credit through: 3/14/2024, 11:59 PM EST
Start Activity

  • Credits Available

    Physicians - maximum of 1.00 AMA PRA Category 1 Credit(s)™

    You Are Eligible For

    • Letter of Completion

Target Audience and Goal Statement

This educational activity is intended for an international audience of non-US pathologists, hematology/oncology specialists, and obstetricians/gynecologists.

The goal of this activity is to enable learners to increase their knowledge and confidence on HER2 testing considering the recent clinical trial data for HER2-low breast cancer.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • HER2 testing guidelines and recommendations for breast cancer
    • Definition of HER2-low in breast cancer
  • Have greater competence related to
    • Selecting patients for HER2 testing
  • Demonstrate greater confidence in their ability to
    • Use HER2 testing to drive treatment decisions in advanced breast cancer


Disclosures

Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.

Disclosures for additional planners can be found here.


Faculty

  • Giuseppe Viale, MD, FRCPath

    Chairman, Department of Pathology & Laboratory Medicine
    European Institute of Oncology
    Milan, Italy

    Disclosures

    Guiseppe Viale, MD, FRCPath, has the following relevant financial relationships:
    Consultant or advisor for: Agilent; AstraZeneca; Bayer; Daiichi Sankyo, Inc.; Dako; Menarini; Merck Sharp & Dohme; Novartis; Pfizer, Inc.; Roche; Ventana Medical Systems
    Speaker or member of speakers bureau for: Agilent; Cepheid; Dako; Roche; Ventana Medical Systems
    Research funding from: Roche

  • Peter A. Fasching, MD

    Associate Professor of Gynecology and Obstetrics Translational Medicine
    University Hospital Erlangen
    Comprehensive Cancer Center Erlangen-EMN
    Erlangen, Germany

    Disclosures

    Peter A. Fasching, MD, has the following relevant financial relationships:
    Consultant or advisor for: Agendia; AstraZeneca; Daiichi Sankyo, Inc.; Eisai, Inc.; Eli Lilly and Company; Gilead Sciences, Inc.; Merck Sharp & Dohme; Novartis; Pfizer, Inc.; Pierre Fabre; Rocha; Sanofi Aventis; Seagen, Inc.
    Speaker or member of speakers bureau for: AstraZeneca; Daiichi Sankyo, Inc.; Eisai, Inc.; Eli Lilly and Company; Gilead Sciences, Inc.; Merck Sharp & Dohme; Novartis; Pfizer, Inc.; Roche; Seagen, Inc.
    Research funding from: Biontech; Cepheid; Pfizer, Inc.

Editors

  • Mihai Surducan, PhD

    Medical Education Director, Medscape, LLC

    Disclosures

    Mihai Surducan, PhD, has no relevant financial relationships.

  • Jason Luis Quiñones, PhD

    Associate Medical Writer, Medscape, LLC

    Disclosures

    Jason Luis Quiñones, PhD, has no relevant financial relationships.

Compliance Reviewer

  • Esther Nyarko, PharmD

    Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Esther Nyarko, PharmD, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.


Accreditation Statements

Medscape

Interprofessional Continuing Education

In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read about the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or print it out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME

HER2 Testing in 2023: Case Studies for Pathologists

Authors: Giuseppe Viale, MD, FRCPath; Peter A. Fasching, MDFaculty and Disclosures

CME Released: 3/14/2023

Valid for credit through: 3/14/2024, 11:59 PM EST

processing....

The following cases are modeled on the interactive grand rounds approach. The questions within the activity are designed to test your current knowledge. After each question, you will be able to see whether you answered correctly and read evidence-based information that supports the most appropriate answer choice. The questions are designed to challenge you; you will not be penalized for answering the questions incorrectly. At the end of the activity, there will be a short post-test assessment based on the material presented.

  • Print